title: Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation.
authors.forename: C
authors.initials: C
authors.lastname: Velik-Salchner
authors.forename: W
authors.initials: W
authors.lastname: Lederer
authors.forename: Fj
authors.initials: F
authors.lastname: Wiedermann
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants / Q000494:pharmacology; D016736:Antiphospholipid Syndrome / Q000503:physiopathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003167:Complement Activation / Q000187:drug effects; D004195:Disease Models, Animal; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D016030:Kidney Transplantation
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D006493:Heparin; C481642:eculizumab